Microorganisms (Horowitz, R., et al.) 09.12.2023, revealed in a particular concern Bartonella and Bartonellosis: New Advances and Further Challenges), “Comparability of the Efficacy of Longer versus Shorter Pulsed Excessive Dose Dapsone Mixture Remedy within the Therapy of Persistent Lyme Illness/Publish Therapy Lyme Illness Syndrome with Bartonellosis and Related Coinfections.”
On this research of twenty-five sufferers (15 males/10 girls) recognized with relapsing and remitting Borreliosis, Babesiosis, and Bartonellosis, over intervals of <5 to over 20 years, acquired double-dose dapsone mixture remedy (DDDCT), adopted by one (or a number of programs) of Excessive Dose Dapsone Mixture Remedy (HDDCT). Remedy resulted in all 25 sufferers displaying enchancment of tick-borne illness signs. Enhancements after remedy administrations have been demonstrated in a retrospective chart assessment of every affected person.
Equal numbers of women and men demonstrated remission after remedy. Sufferers with publicity to a number of Babesia spp. and a number of other Bartonella spp. have been noticed to be a few of the sickest and most therapy resistant. It’s famous that sufferers with Bartonellosis finishing 6–7 day pulses of HDDCT confirmed a larger degree of enchancment, versus sufferers that acquired 4-day pulses of remedy.
Moreover, over 30% of sufferers who accomplished 8 weeks of DDDCT adopted by a 5–7 day pulse of HDDCT, confirmed sustained remission of their signs for 3-9 months. One other 13% of sufferers who lately completed therapy have been 1 ½ months into full remission of signs. Full remission is outlined “because the decision of all lively tick-borne signs for at the least 3 months post-therapy.”
This novel remedy reveals promise of sustained remission of Lyme, Babesiosis and Bartonellosis signs in sufferers which have failed prior antibiotic protocols.
For Extra Info:
The publish Novel Treatment for Relapsing Lyme, Babesia, & Bartonella Infections appeared first on Lyme Disease Association.